HighVista Strategies’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.57M	Sell	33,852 -39,693	-54%	-$3.51M	0.99%	28
2025 Q4	$6.42M	Sell	73,545 -48,137	-40%	-$3.94M	1.65%	14
2025 Q3	$8.08M	Buy	121,682 +63,831	+110%	+$3.63M	1.98%	6
2025 Q2	$3.2M	Sell	57,851 -20,601	-26%	-$989K	1.18%	14
2025 Q1	$3.79M	Buy	78,452 +15,934	+25%	+$668K	1.46%	6
2024 Q4	$2.41M	Sell	62,518 -26,990	-30%	-$1.18M	0.9%	30
2024 Q3	$4.03M	Buy	89,508 +68,279	+322%	+$2.76M	1.39%	12
2024 Q2	$736K	Hold	21,229	–	–	0.27%	106
2024 Q1	$614K	Sell	21,229 -7,130	-25%	-$194K	0.22%	111
2023 Q4	$650K	Buy	+28,359	New	+$496K	0.24%	107
2023 Q3	–	Sell	-29,179	Closed	-$806K	–	158
2023 Q2	$806K	Buy	+29,179	New	+$730K	0.37%	66
2022 Q3	–	Sell	-46,459	Closed	-$367K	–	125
2022 Q2	$367K	Sell	46,459 -45,586	-50%	-$551K	0.22%	84
2022 Q1	$2.18M	Buy	92,045 +61,046	+197%	+$1.72M	1.39%	20
2021 Q4	$1.06M	Buy	30,999 +2,688	+9%	+$85K	0.84%	42
2021 Q3	$501K	Buy	28,311 +2,458	+10%	+$105K	0.33%	71
2021 Q2	$1.16M	Buy	+25,853	New	+$853K	0.82%	17